Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Ell

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
Nuclear Medicine Communications|January 20, 2005
How often do patients undergo repeat PET or PET/CT examinations? Experience from a UK institutionAshley M Groves, Ian Cullum, Rizwan Syed, et al.
Synapse (New York, N.Y.)|May 23, 2006
[123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challengeJames M Stone, Erik Arstad, Kjell Erlandsson, et al.
International Journal of Cardiology|July 20, 2002
Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphyMark G Gunning, Judith Walker, Sian Eastick, et al.
Hormones and Behavior|December 19, 2006
Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET studyRay Norbury, Michael J Travis, Kjell Erlandsson, et al.
Atherosclerosis|March 6, 2010
What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaqueLeon J Menezes, Irfan Kayani, Simona Ben-Haim, et al.
Nuclear Medicine Communications|October 7, 2008
Clinical governance improves the quality of nuclear medicine reportingA Michael Peters, Jamshed Bomanji, Peter J Ell, et al.
Neuroimage|July 26, 2003
Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findingsKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Nuclear Medicine Communications|September 24, 2013
Clinical evaluation of reducing acquisition time on single-photon emission computed tomography image quality using proprietary resolution recovery softwareMatthew D Aldridge, Wendy W Waddington, John C Dickson, et al.
Pharmaceutical Research|October 31, 2002
Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidineAbdul W Basit, Fridrun Podczeck, J Michael Newton, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
Schizophrenia Research|June 27, 2002
Typical antipsychotic drugs -- D(2) receptor occupancy and depressive symptoms in schizophreniaRodrigo A Bressan, Durval C Costa, Hugh M Jones, et al.
Nuclear Medicine Communications|January 20, 2005
How often do patients undergo repeat PET or PET/CT examinations? Experience from a UK institutionAshley M Groves, Ian Cullum, Rizwan Syed, et al.
Synapse (New York, N.Y.)|May 23, 2006
[123I]TPCNE--a novel SPET tracer for the sigma-1 receptor: first human studies and in vivo haloperidol challengeJames M Stone, Erik Arstad, Kjell Erlandsson, et al.
International Journal of Cardiology|July 20, 2002
Exercise training following myocardial infarction improves myocardial perfusion assessed by thallium-201 scintigraphyMark G Gunning, Judith Walker, Sian Eastick, et al.
Hormones and Behavior|December 19, 2006
Estrogen therapy and brain muscarinic receptor density in healthy females: a SPET studyRay Norbury, Michael J Travis, Kjell Erlandsson, et al.
Atherosclerosis|March 6, 2010
What is the natural history of 18F-FDG uptake in arterial atheroma on PET/CT? Implications for imaging the vulnerable plaqueLeon J Menezes, Irfan Kayani, Simona Ben-Haim, et al.
Nuclear Medicine Communications|October 7, 2008
Clinical governance improves the quality of nuclear medicine reportingA Michael Peters, Jamshed Bomanji, Peter J Ell, et al.
Neuroimage|July 26, 2003
Analysis of D2 dopamine receptor occupancy with quantitative SPET using the high-affinity ligand [123I]epidepride: resolving conflicting findingsKjell Erlandsson, Rodrigo A Bressan, Rachel S Mulligan, et al.
Nuclear Medicine Communications|September 24, 2013
Clinical evaluation of reducing acquisition time on single-photon emission computed tomography image quality using proprietary resolution recovery softwareMatthew D Aldridge, Wendy W Waddington, John C Dickson, et al.
Pharmaceutical Research|October 31, 2002
Influence of polyethylene glycol 400 on the gastrointestinal absorption of ranitidineAbdul W Basit, Fridrun Podczeck, J Michael Newton, et al.
Pageof 10